Free Content Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea

Authors: YEARSLEY, K. A.1; GILBY, L. J.1; RAMADAS, A. V.1; KUBIAK, E. M.2; FONE, D. L.3; ALLISON, M. C.1

Source: Alimentary Pharmacology & Therapeutics, Volume 24, Number 4, August 2006 , pp. 613-619(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Summary Background

Inhibition of gastric acid removes a defence against ingested bacteria and spores, increasing the risk of some forms of gastroenteritis. Previous studies investigating a possible link between acid suppression therapy and Clostridium difficile-associated diarrhoea have reported conflicting results. Aim

To investigate whether acid suppression therapy is associated with an increased risk of C. difficile-associated diarrhoea. Methods

Prospective case-control study of 155 consecutive in-patients with C. difficile-associated diarrhoea. Results

Antibiotics had been received by 143 (92%) of the C. difficile-associated diarrhoea group and 76 (50%) of the controls during the preceding 3 months. Among those receiving antibiotics, 59 (41%) of the C. difficile-associated diarrhoea group had also received acid suppression, compared with 21 (28%) of controls (OR 1.84, CI 1.01, 3.36, χ2 = 4.0, P = 0.046). Among the entire C. difficile-associated diarrhoea group 64 (41%) had received acid suppression compared with 40 (26%) of controls (OR 1.99, CI 1.19, 3.31, χ2 = 7.9, P = 0.005). Logistic regression analyses found that C. difficile-associated diarrhoea was independently associated with: antibiotic use (OR 13.1, 95% CI: 6.6, 26.1); acid suppression therapy (OR 1.90, 95% CI: 1.10, 3.29); and female sex (OR 1.79, 95% CI: 1.06, 3.04). Conclusions

The risk of C. difficile-associated diarrhoea in hospitalized patients receiving antibiotics may be compounded by exposure to proton pump inhibitor therapy.

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2036.2006.03015.x

Affiliations: 1: Adult Medicine 2: Microbiology, Royal Gwent Hospital, Newport, South Wales 3: Department of Epidemiology, Statistics and Public Health, Centre for Health Sciences Research, School of Medicine, Cardiff University, Heath Park, Cardiff, UK

Publication date: 2006-08-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page